Gary Patou, Director at OSCIENT PHARMACEUTICALS CORP (OSCI), sold 30,000 shares at $2.10 ($63K) on 2006-03-20, disclosed to the SEC on 2006-03-22.
Scheduled sale ($63k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 10,000 | $21K | 32.9% |
| 2 | $2.10 | 10,000 | $21K | 33.2% |
| 3 | $2.15 | 10,000 | $22K | 34.0% |
| Total | $2.11 avg | 30,000 | $63K | 100% |
| Filing → |
| XENE | SELL | 2023-12-15 | $624K | — | Filing → |
| XENE | SELL | 2023-12-15 | $1.0M | — | Filing → |
| XENE | SELL | 2022-11-28 | $276K | — | Filing → |